Schawo, S., van der Kolk, A., Bouwmans, C., Annemans, L., Postma, M., Buitelaar, J., . . . Hakkaart-van Roijen, L. (2015). Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed? Pharmacoeconomics.
Citação norma ChicagoSchawo, Saskia, Annemarie van der Kolk, Clazien Bouwmans, Lieven Annemans, Maarten Postma, Jan Buitelaar, Michel van Agthoven, and Leona Hakkaart-van Roijen. "Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information Is Needed?" Pharmacoeconomics 2015.
Citação norma MLASchawo, Saskia, et al. "Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information Is Needed?" Pharmacoeconomics 2015.